Quick Answer
LIGAND PHARMACEUTICALS INC reported Net Income of $124.45 million for fiscal year 2025.
LIGAND PHARMACEUTICALS INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $124.45M | +3186.6% |
| 2024 | -$4.03M | -107.7% |
| 2023 | $52.15M | +256.3% |
| 2022 | -$33.36M | -158.4% |
| 2021 | $57.14M | +2014.2% |
| 2020 | -$2.98M | -100.5% |
| 2019 | $629.30M | +339.1% |
| 2018 | $143.32M | +1041.5% |
| 2017 | $12.56M | +867.5% |
| 2016 | -$1.64M | -100.7% |
| 2015 | $229.82M | +1811.4% |
| 2014 | $12.02M | +5.3% |
| 2013 | $11.42M | +2267.0% |
| 2012 | -$527.0K | -105.4% |
| 2011 | $9.71M | +193.7% |
| 2010 | -$10.37M | -432.5% |
| 2009 | -$1.95M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $117.27M | +1735.2% | +2319.5% |
| June 30, 2025 | $4.85M | +109.3% | +111.4% |
| March 31, 2025 | -$42.45M | -149.3% | -491.9% |
| September 30, 2024 | -$7.17M | +30.2% | +86.2% |
| June 30, 2024 | -$51.91M | -2366.9% | -160.3% |
| March 31, 2024 | $86.14M | +105.3% | +938.5% |
| September 30, 2023 | -$10.27M | -2642.8% | -548.6% |
| June 30, 2023 | $2.29M | +355.9% | -94.5% |
- LIGAND PHARMACEUTICALS INC showed an increase of +3186.6% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, LIGAND PHARMACEUTICALS INC’s net income has grown by 6488.8% (from -$1.95 million to $124.45 million).
- The most recent figure is from LIGAND PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: